Remimazolam

Generic Name
Remimazolam
Brand Names
Byfavo
Drug Type
Small Molecule
Chemical Formula
C21H19BrN4O2
CAS Number
308242-62-8
Unique Ingredient Identifier
7V4A8U16MB
Background

Remimazolam is an ultra short-acting benzodiazepine used in the induction and maintenance of sedation during short (<30 minute) procedures. Recent trends in anesthesia-related drug development have touted the benefits of so-called "soft drugs" - these agents, such as remifentanil, are designed to be metabolically fragile and thus susceptible to rapid biotran...

Indication

Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.

Associated Conditions
Procedural Sedation
Associated Therapies
-

Dose of Remi in Children

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-08-14
Last Posted Date
2023-08-14
Lead Sponsor
Zhihong LU
Target Recruit Count
25
Registration Number
NCT05990673

Remimazolam for Cataract Surgery

Phase 4
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-08-07
Last Posted Date
2024-12-13
Lead Sponsor
University of California, Los Angeles
Target Recruit Count
120
Registration Number
NCT05980117
Locations
🇺🇸

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles, California, United States

The Effect of Remimazolam and Dexmedetomidine on the Incidence of Hypotension During Spinal Anesthesia

Not Applicable
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-07-07
Last Posted Date
2023-08-08
Lead Sponsor
Pusan National University Yangsan Hospital
Target Recruit Count
72
Registration Number
NCT05935657

Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation

First Posted Date
2023-06-18
Last Posted Date
2024-08-12
Lead Sponsor
Pusan National University Yangsan Hospital
Target Recruit Count
66
Registration Number
NCT05907525
Locations
🇰🇷

Pusan National University Yangsan Hospital, Yangsan, Please Select, Korea, Republic of

Remimazolam for Postoperative Atrial Fibrillation

First Posted Date
2023-06-06
Last Posted Date
2023-06-06
Lead Sponsor
Yangzhou University
Target Recruit Count
50
Registration Number
NCT05891145
Locations
🇨🇳

The Affiliated Hospital of Yangzhou University., Yangzhou, Jiangsu, China

The Effect of Remimazolam on Opioid Induced Hyperalgesia

First Posted Date
2023-05-19
Last Posted Date
2023-10-06
Lead Sponsor
Wonkwang University Hospital
Target Recruit Count
108
Registration Number
NCT05866315
Locations
🇰🇷

Wonkwag UH, Iksan, Jeollabukdo, Korea, Republic of

🇰🇷

Wonkwang University hospital, Iksan, Korea, Republic of

Remimazolam Versus Midaszolam for Sedation in Diagnostic Upper Gastrointestinal Endoscopy

Phase 3
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-05-01
Last Posted Date
2023-05-01
Lead Sponsor
Samsung Medical Center
Target Recruit Count
132
Registration Number
NCT05836545
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Continuous Infusion of Remidazolam for Colonoscopic Polypectomy in Elderly Patients

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2023-04-06
Last Posted Date
2024-08-13
Lead Sponsor
Tongji Hospital
Target Recruit Count
114
Registration Number
NCT05801757
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Comparative Study of Recovery Characteristics Between Remimazolam Anesthesia With Flumazenil and Desflurane Anesthesia for Closed Reduction of Nasal Bone Fracture

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2023-03-17
Last Posted Date
2023-09-07
Lead Sponsor
Daegu Catholic University Medical Center
Target Recruit Count
58
Registration Number
NCT05774366
Locations
🇰🇷

Daegu Catholic University Medical Center, Daegu, Korea, Republic of

Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia

Phase 4
Not yet recruiting
Conditions
Interventions
First Posted Date
2023-03-08
Last Posted Date
2023-03-08
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
110
Registration Number
NCT05760534
© Copyright 2024. All Rights Reserved by MedPath